| http://www.w3.org/ns/prov#value | - 01 MAR 2013: Wright Medical Group acquired BioMimetic Therapeutics for $380m or $12.97 per share, based on Wright???s closing stock price on 16 NOV 2012.BioMimetic Therapeutics (BMTI) was a Tennessee based biotechnology company focused on development & marketing of clinically proven products to promote the healing of musculoskeletal injuries & diseases, including therapies for orthopaedic & sports
|
